West Pharmaceutical Services Inc (WST)
Operating profit margin
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating income (ttm) | US$ in thousands | 574,500 | 575,800 | 591,800 | 643,500 | 676,000 | 613,700 | 575,500 | 621,400 | 655,800 | 741,200 | 783,500 | 766,400 | 752,300 | 684,400 | 602,200 | 494,500 | 406,900 | 368,900 | 337,000 | 313,900 |
Revenue (ttm) | US$ in thousands | 2,893,100 | 2,876,300 | 2,876,800 | 2,928,600 | 2,949,800 | 2,926,500 | 2,866,000 | 2,883,500 | 2,886,900 | 2,909,000 | 2,928,600 | 2,880,900 | 2,831,600 | 2,681,000 | 2,522,500 | 2,326,100 | 2,146,900 | 2,037,300 | 1,945,400 | 1,887,900 |
Operating profit margin | 19.86% | 20.02% | 20.57% | 21.97% | 22.92% | 20.97% | 20.08% | 21.55% | 22.72% | 25.48% | 26.75% | 26.60% | 26.57% | 25.53% | 23.87% | 21.26% | 18.95% | 18.11% | 17.32% | 16.63% |
December 31, 2024 calculation
Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $574,500K ÷ $2,893,100K
= 19.86%
The operating profit margin of West Pharmaceutical Services Inc has shown a generally increasing trend from March 2020 to June 2022, reaching a peak of 26.75% in June 2022. This indicates that the company was effectively managing its operating expenses in relation to its revenue during this period.
However, from September 2022 onwards, the operating profit margin started to decline gradually, dropping to 19.86% by December 2024. This decrease suggests that the company may have faced challenges in controlling its operating costs or experienced a decrease in revenue relative to its expenses during this period.
Overall, the operating profit margin data reveals both strengths and potential areas of concern in West Pharmaceutical Services Inc's ability to generate profits from its core operations over the analyzed period.
Peer comparison
Dec 31, 2024